Birth Control Pills May Protect Against Gynecologic Cancers
Dr. Marina Stasenko, a member of NYU Langone’s Perlmutter Cancer Center, discusses a study on birth control pills and cancer prevention.
Bispecific Antibodies Tested for Solid Tumors
Dr. Kristen Spencer, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, leads a study of bispecific antibodies for solid tumors.
Black Americans Urged to Get Regular Colon Cancer Screening
Perlmutter Cancer Center doctors recommend Black men and women start colorectal cancer screenings at age 45 because of higher rates of disease.
Black Men Are at Increased Risk for Prostate Cancer
Dr. Joseph E. Ravenell, a public health expert at NYU Langone’s Perlmutter Cancer Center, discusses prostate cancer risk factors for Black men.
Black Scholars in Substance Abuse January 2021
Name Relevant area Affiliation Selected Papers Site Twitter handle A. Kathleen Burlew, PhD HIV risk prevention ...
Blink Assessment Essential for Face Transplants
A retrospective research study concludes that careful blink assessment is essential in facial transplantation procedures in order to ensure optimal long-term vision for transplant recipients.
Blood & Marrow Transplant Program Expands Services
NYU Langone’s Blood and Marrow Transplant Program expands services and receives accreditation for adult allogeneic transplants.
Blood Cancer Pilot Grants Support Translational Research
Pilot grant funding from the Center for Blood Cancers, part of NYU Langone’s Perlmutter Cancer Center, aims to spur new ideas for treatment.
Blood Plasma May Hold the Key to Treating COVID-19
NYU Langone researchers are looking at blood plasma from people who have recovered from COVID-19 as a potential treatment for the virus.
Blood Pressure Drugs Work Against Deadly Malaria Symptom
A study at NYU Langone found that adding a blood pressure medication to the standard drug used to treat malaria may reduce bleeding deaths.